Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 349 Results
Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019
September 11, 2019
Palatin Technologies Granted FDA Orphan Drug Designation — PL-8177 for the Treatment of Non-Infectious Uveitis
June 6, 2019
Page 18 of 35